Assertio Announces Partnership with the Lennox-Gastaut Syndrome (LGS) FoundationGlobeNewsWire • 01/17/23
Assertio Holdings, Inc. Announces FDA Orange Book Listing for New Sympazan® Oral Film PatentGlobeNewsWire • 01/09/23
After Golden Cross, Assertio (ASRT)'s Technical Outlook is BrightZacks Investment Research • 12/21/22
Assertio Holdings, Inc. to Host Investor and Business Development Meetings January 9-11, 2023 in San FranciscoGlobeNewsWire • 12/13/22
Assertio Increases Full-Year Net Product Sales Outlook to in Excess of $152 MillionGlobeNewsWire • 12/05/22
Assertio Holdings, Inc. to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022GlobeNewsWire • 10/27/22
Assertio Holdings, Inc. Signs Exclusive License for Sympazan® (clobazam) Oral Film from Aquestive Therapeutics, Inc.GlobeNewsWire • 10/27/22